Status:
COMPLETED
Lifestyle Intervention for Prevention of Gestational Diabetes Mellitus in the UAE Population
Lead Sponsor:
Rashid Centre for Diabetes and Research
Conditions:
Gestational Diabetes Mellitus in Pregnancy
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Gestational diabetes mellitus (GDM) is a high blood glucose (hyperglycemia) first occurring or first recognized during pregnancy, it is affecting 16.4% of women globally and 36.6 % in this region. It ...
Detailed Description
Gestational diabetes mellitus (GDM) is a high blood glucose (hyperglycemia) first occurring or first recognized during pregnancy, it is affecting 16.4% of women globally and 36.6 % in this region. It ...
Eligibility Criteria
Inclusion
- The study will include pregnant females (≤ 12 weeks of gestation), singleton pregnancy who meet ≥ 2 risk factors for GDM stated below:
- High Risk ethnic group (South Asian, Middle Eastern, Black Carribean)
- Family history of type 2 diabetes, especially in first-degree relatives
- previous macrosomic baby weighing \>4.5 kg
- Body mass index greater than 30 kg/m2
- Previous history of GDM or polycystic ovarian syndrome
Exclusion
- Any form of pregestational diabetes
- Fasting glucose \> 126 mg/dL at first prenatal visit.
- Currently using corticosteroids, metformin or other medications interfering with glucose metabolism
- Psychiatric disorders
- Medical conditions preventing any physical exercise.
Key Trial Info
Start Date :
October 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04273412
Start Date
October 13 2018
End Date
July 30 2021
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rashid Centre for Diabetes and Research
Ajman, United Arab Emirates